Figure 3. Associations of MAPKBP1 expression with clinical outcome in ELN genetic groups.
(A) EFS and (B) OS of CN-AML patients in the ELN favourably genetic group. (C) EFS and (D) OS of CN-AML patients in the ELN intermediate-I genetic group.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.